Literature DB >> 11465952

T cell proliferation and cytokine secretion to T cell epitopes of Asp f 2 in ABPA patients.

V B Rathore1, B Johnson, J N Fink, K J Kelly, P A Greenberger, V P Kurup.   

Abstract

The pathogenesis of allergic bronchopulmonary aspergillosis (ABPA) involves specific cytokines secreted by lymphocytes in response to Aspergillus fumigatus (Af) allergens. To gain information about the lymphoproliferative response and cytokine production against a major Af allergen, Asp f 2, we studied Asp-f-2-specific T cell clones (TCCs) from ABPA patients. TCCs were stimulated with rAsp f 2, its deletion mutants, and synthetic peptides to identify the T cell epitope(s) and to understand cytokine production. PBMCs from four of five ABPA patients showed proliferation in response to Asp f 2. Three TCCs from one patient showed higher IL-5 secretion compared to IL-4 and IFN-gamma. Two TCCs from the second patient showed a mixed Th1/Th2 response, as evidenced by production of IL-4, IL-5, and IFN-gamma. An epitope from the N-terminal region of Asp f 2 induced only IL-5 secretion. High IL-5 secretion might explain the marked eosinophilia observed in ABPA patients. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465952     DOI: 10.1006/clim.2001.5056

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

1.  Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen.

Authors:  G Ramadan; B Davies; V P Kurup; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice.

Authors:  C S Barrios; B D Johnson; J D Henderson; J N Fink; K J Kelly; V P Kurup
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 3.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

Review 4.  Fungal allergens.

Authors:  Viswanath P Kurup
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

5.  Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?

Authors:  Carlo Mümmler; Bernd Kemmerich; Jürgen Behr; Nikolaus Kneidinger; Katrin Milger
Journal:  Allergy Asthma Clin Immunol       Date:  2020-06-26       Impact factor: 3.406

6.  A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.

Authors:  Takeshi Terashima; Taro Shinozaki; Eri Iwami; Takahiro Nakajima; Tatsu Matsuzaki
Journal:  BMC Pulm Med       Date:  2018-03-27       Impact factor: 3.317

7.  The Use of Targeted Monoclonal Antibodies in the Treatment of ABPA-A Case Series.

Authors:  Aoife O'Reilly; Eleanor Dunican
Journal:  Medicina (Kaunas)       Date:  2021-12-29       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.